133 related articles for article (PubMed ID: 7781210)
1. [Clinical and biochemical analysis of 27 patients with myoglobinuria of unknown causes].
Tsurui S; Sugie H; Ito M; Igarashi Y
Rinsho Shinkeigaku; 1995 Jan; 35(1):24-8. PubMed ID: 7781210
[TBL] [Abstract][Full Text] [Related]
2. Metabolic causes of myoglobinuria.
Tonin P; Lewis P; Servidei S; DiMauro S
Ann Neurol; 1990 Feb; 27(2):181-5. PubMed ID: 2156480
[TBL] [Abstract][Full Text] [Related]
3. Recurrent myoglobinuria due to carnitine palmitoyltransferase II deficiency: clinical, biochemical, and genetic features of adult-onset cases.
Kilfoyle D; Hutchinson D; Potter H; George P
N Z Med J; 2005 Feb; 118(1210):U1320. PubMed ID: 15776096
[TBL] [Abstract][Full Text] [Related]
4. Recurrent childhood myoglobinuria.
Tein I; DiMauro S; DeVivo DC
Adv Pediatr; 1990; 37():77-117. PubMed ID: 2264536
[TBL] [Abstract][Full Text] [Related]
5. Carnitine palmitoyltransferase deficiency: a common cause of recurrent myoglobinuria.
Sadeh M; Gutman A
Isr J Med Sci; 1990 Sep; 26(9):510-5. PubMed ID: 2228562
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical analysis using biopsied muscle in 72 patients with metabolic myopathies].
Sugie H; Tsurui S; Sugie Y; Suzuki M; Miyamoto R
Rinsho Shinkeigaku; 1989 May; 29(5):584-7. PubMed ID: 2791407
[TBL] [Abstract][Full Text] [Related]
7. [Exercise-induced muscular weakness, myalgia and contractures. I. A clinical review].
Mattle H; Jerusalem F
Schweiz Med Wochenschr; 1977 Apr; 107(13):428-36. PubMed ID: 139680
[TBL] [Abstract][Full Text] [Related]
8. Disorders of lipid metabolism in muscle.
Di Mauro S; Trevisan C; Hays A
Muscle Nerve; 1980; 3(5):369-88. PubMed ID: 7421873
[TBL] [Abstract][Full Text] [Related]
9. Metabolic myopathies: evaluation by graded exercise testing.
Elliot DL; Buist NR; Goldberg L; Kennaway NG; Powell BR; Kuehl KS
Medicine (Baltimore); 1989 May; 68(3):163-72. PubMed ID: 2716515
[TBL] [Abstract][Full Text] [Related]
10. Respiratory chain deficiency presenting as recurrent myoglobinuria in childhood.
de Lonlay-Debeney P; Edery P; Cormier-Daire V; Parfait B; Chrétien D; Rötig A; Romero N; Saudubray JM; Munnich A; Rustin P
Neuropediatrics; 1999 Feb; 30(1):42-4. PubMed ID: 10222461
[TBL] [Abstract][Full Text] [Related]
11. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.
Ørngreen MC; Dunø M; Ejstrup R; Christensen E; Schwartz M; Sacchetti M; Vissing J
Ann Neurol; 2005 Jan; 57(1):60-6. PubMed ID: 15622536
[TBL] [Abstract][Full Text] [Related]
12. Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects.
Deschauer M; Wieser T; Zierz S
Arch Neurol; 2005 Jan; 62(1):37-41. PubMed ID: 15642848
[TBL] [Abstract][Full Text] [Related]
13. A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.
Vladutiu GD; Bennett MJ; Smail D; Wong LJ; Taggart RT; Lindsley HB
Mol Genet Metab; 2000 Jun; 70(2):134-41. PubMed ID: 10873395
[TBL] [Abstract][Full Text] [Related]
14. Trifunctional enzyme deficiency: adult presentation of a usually fatal beta-oxidation defect.
Schaefer J; Jackson S; Dick DJ; Turnbull DM
Ann Neurol; 1996 Oct; 40(4):597-602. PubMed ID: 8871579
[TBL] [Abstract][Full Text] [Related]
15. [Lipidic myopathies].
Muñoz-Blanco JL
Rev Neurol; 1998 Apr; 26 Suppl 1():S72-80. PubMed ID: 9810593
[TBL] [Abstract][Full Text] [Related]
16. [Myoglobinuria and carnitine palmitoyltransferase deficiency. Diagnostic procedure and differential diagnosis].
Kiechl S; Kohlendorfer U; Paetzke I; Sperl W; Rainer J; Willeit J
Wien Klin Wochenschr; 1994; 106(6):174-7. PubMed ID: 8197749
[TBL] [Abstract][Full Text] [Related]
17. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency.
Corti S; Bordoni A; Ronchi D; Musumeci O; Aguennouz M; Toscano A; Lamperti C; Bresolin N; Comi GP
J Neurol Sci; 2008 Mar; 266(1-2):97-103. PubMed ID: 17936304
[TBL] [Abstract][Full Text] [Related]
19. Metabolic myopathies: update 2009.
van Adel BA; Tarnopolsky MA
J Clin Neuromuscul Dis; 2009 Mar; 10(3):97-121. PubMed ID: 19258857
[TBL] [Abstract][Full Text] [Related]
20. [Intolerance to exercise caused by carnitine palmitoyltransferase deficiency].
Desnuelle C; Pellissier JF; de Barsy T; Serratrice G
Rev Neurol (Paris); 1990; 146(3):231-4. PubMed ID: 2184487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
